NANOGHOSTS

NanoGhostsโ€™ technology is based on its founderโ€™s research, that the Technion's commercial unit has patented in the U.S. and Europe.

#SimilarOrganizations #People #Financial #More

NANOGHOSTS

Industry:
Biotechnology Health Care

Founded:
2019-01-01

Address:
Tel Aviv, Tel Aviv, Israel

Country:
Israel

Total Employee:
1+

Status:
Active

Total Funding:
5 M USD


Similar Organizations

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

healthwire-logo

Healthwire

Healthwire is a health-tech startup.

ivf-access-logo

IVF Access

IVF Access is a healthcare startup.

janpix-logo

Janpix

Janpix operates as an oncology-focused startup.

protai-logo

Protai

Protai is an AI-powered drug discovery startup.

Current Employees Featured

yonatan-malca_image

Yonatan Malca
Yonatan Malca Chief Executive Officer @ NanoGhosts
Chief Executive Officer
2019-11-01

marcelle-machluf_image

Marcelle Machluf
Marcelle Machluf Co-Founder and inventor @ NanoGhosts
Co-Founder and inventor

Founder


marcelle-machluf_image

Marcelle Machluf

Investors List

amoon_image

aMoon Fund

aMoon Fund investment in Venture Round - NanoGhosts

More informations about "NanoGhosts"

Targeted Drug Delivery Platform | Company - NanoGhost

NanoGhosts can be loaded with various drug types (i.e. small molecules, DNA, RNA, peptides, proteins), preserve MSCโ€™s tropism to cancer cells, and selectively penetrate tumors (as demonstrated in various preclinical models of solid โ€ฆSee details»

NanoGhosts - Crunchbase Company Profile & Funding

Organization. NanoGhosts . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. NanoGhosts is a cancer drug startup. Tel Aviv, โ€ฆSee details»

NanoGhost - LinkedIn

NanoGhost is a biotech company that develops a highly selective first-in-class drug delivery platform (Nano-Ghosts/NGs) from the cell membrane of mesenchymal stem cells (MSCs), cells with known ...See details»

NanoGhost 2025 Company Profile: Valuation, Funding โ€ฆ

NanoGhost General Information Description. Developer of a drug-delivery technology designed to shrink the deadliest forms of cancer by precisely โ€ฆSee details»

NanoGhost - aMoon

NanoGhosts can be loaded with various drug types, preserve MSCs tropism to cancer cells, and selectively penetrate tumors, leading to a major reduction in tumor size and prolonged survival.See details»

NanoGhost - Israeli Startup | Startup Nation Finder

May 20, 2020 Work Email* (please provide your email in the organization) Position* Notes. Send Create Free Account. Create Free Account. 8 Characters, Uppercase letter (A-Z), Lowercase โ€ฆSee details»

NanoGhost - Products, Competitors, Financials, Employees, โ€ฆ

Life Sciences Venture Fund aMoon Invests $5 Million in Cancer Drug Company NanoGhosts turns stem cells into a drug delivery system that specifically targets cancerous tumors Hagar โ€ฆSee details»

NanoGhosts for a targeted fight against cancer - Haaretz

Jan 14, 2025 Targeted Cancer Treatments Are Currently Considered the Hottest Field in the Biotech World. NanoGhost, an Israeli Biotech Company, Brings One of the Most Innovative โ€ฆSee details»

Nano-Ghosts: A naturally targeted drug and gene delivery system

Nanoghosts derived from mesenchymal stem cells and retaining their unique surface-associated tumor-targeting capabilities were redesigned as a selective and safe universal nonviral gene โ€ฆSee details»

NanoGhost | Targeted Drug Delivery Platform | Home

NanoGhost is a biotech company that develops a highly selective first-in-class drug delivery platform (Nano-Ghosts/NGs) from the cell membrane of mesenchymal stem cells (MSCs), cells with known tropism to cancer and sites โ€ฆSee details»

Targeted Drug Delivery Platform | Technology

NGs are nanovesicles derived from the cell membranes of allogeneic Mesenchymal Stem Cells (MSCs). Using the NanoGhost technology, MSCs are emptied from their intracellular content and the cell membrane is downsized to โ€ฆSee details»

Nanoghosts: Mesenchymal Stem cells derived ... - ScienceDirect

Sep 10, 2021 In previous research, we reported the potential of a new biomimetic tumor-targeted platform, called nanoghosts (NGs), which can work as vehicles for drug-delivery. NGs โ€ฆSee details»

NanoGhosts for a Targeted Fight Against Cancer - Technion

Published By: Editors at Haaretz Publish Date: January 14, 2025 Targeted cancer treatments are currently considered the hottest field in the biotech world. NanoGhost, an Israeli biotech โ€ฆSee details»

NanoGhost - VentureRadar

"NanoGhost is a biotech company that develops a highly selective first-in-class drug delivery platform (Nano-Ghosts/NGs) from the cell membrane of mesenchymal stem cells (MSCs), โ€ฆSee details»

NanoGhosts - Contacts, Employees, Board Members, Advisors

NanoGhosts is a cancer drug startup. Start Free Trial . Chrome ExtensionSee details»

Nanoghosts: Harnessing Mesenchymal Stem Cell Membrane for โ€ฆ

Aug 31, 2023 These cargoes are so called โ€œnanoghosts.โ€ This review article summarizes the current applications of nanoghosts, the promising potential of MSCs to be applied in โ€ฆSee details»

Reconstructed Stem Cell Nanoghosts: A Natural Tumor Targeting โ€ฆ

Jun 20, 2013 The ultimate goal in cancer therapy is achieving selective targeting of cancer cells. We report a novel delivery platform, based on nanoghosts (NGs) produced from the โ€ฆSee details»

NanoGhosts - Funding, Financials, Valuation & Investors

Dec 24, 2020 How much funding has this organization raised over time? Show . Announced Date . Transaction Name ... Money Raised . Lead Investors . Dec 24, 2019: Venture Round - โ€ฆSee details»

Nanoghosts: Mesenchymal Stem cells derived nanoparticles as a

Sep 10, 2021 Osteoarthritis (OA) is a chronic degenerative disease, which affects the joints and is characterized by inflammation, cartilage loss and bone changes. Nowadays, there are no โ€ฆSee details»

Nanoghosts as a Novel Natural Nonviral Gene Delivery Platform โ€ฆ

Mar 9, 2016 Nanoghosts derived from mesenchymal stem cells and retaining their unique surface-associated tumor-targeting capabilities were redesigned as a selective and safe โ€ฆSee details»

linkstock.net © 2022. All rights reserved